Dr. Hirsch received his medical degree from the University of Missouri School of Medicine in 1984. He completed residency training in internal medicine at the University of Miami, in Miami, Florida and Mount Sinai Hospital in Miami Beach, Florida and a research fellowship at Washington University School of Medicine in St. Louis. From both a research and teaching point of view, Dr. Hirsch’s career has focused on studying the best strategies for the use of insulin therapy in both type 1 and type 2 diabetes.
In the past 5 years, he has become involved with artificial pancreas technology and better understanding on the limitations of diabetes biomarkers. With regards to patient care, most patients in his practice have type 1 diabetes or atypical forms of diabetes. Over the years, he has been a passionate advocate for patients ensuring access and affordability for glucose monitoring technology and in the past decade, insulin. Dr. Hirsch has authored more than 280 research papers, more than 60 editorials (including the New England Journal of Medicine and JAMA), and numerous book chapters in addition to six books for patients and physicians.
Dr. Hirsch is the former chair of the Professional Practice Committee for the American Diabetes Association and has served as editor-in-chief of two ADA journals, “Clinical Diabetes” and “DOC News”. He is an Associate Editor of “Diabetes Technology and Therapeutics” and has been on the editorial board of “Diabetes Care”. Awards include the JK Lilly Distinguished Service Award from the American Diabetes Association, the Laureate Award, Outstanding Public Service award from the Endocrine Society, the Centennial Award from Advanced Technology & Treatment of Diabetes and the Samuel Eichold II Memorial Award for Contributions in Diabetes from the American College of Physicians He has also served as a member of the American Board of Internal Medicine.
